Sign In
Buy PRVB
$24.98
+0 (+0%)
At Close: Jul 24, 2023
Los Angeles, California--(Newsfile Corp. - May 28, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Provention Bio, Inc.
FDA Advisory Committee Votes In Favor Of Approval Of Provention Bio's Diabetes Med
07:56am, Friday, 28'th May 2021
The FDA's Endocrinologic and Metabolic Drugs Advisory Committee voted 10-7 in favor of recommending approval of Provention Bio Inc's (NASDAQ: PRVB) teplizumab to delay the development of type 1 di
RED BANK, N.J., May 27, 2021 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that th
New York, New York--(Newsfile Corp. - May 27, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of P
NEW YORK, May 27, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Provention B
The Law Offices of Frank R. Cruz Announces Investigation of Provention Bio, Inc. (PRVB) on Behalf of Investors
01:00pm, Thursday, 27'th May 2021
LOS ANGELES--(BUSINESS WIRE)---- $PRVB #investors--The Law Offices of Frank R. Cruz Announces Investigation of Provention Bio, Inc. (PRVB) on Behalf of Investors
Los Angeles, California--(Newsfile Corp. - May 27, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Provention Bio, Inc.
Provention Bio Stock Trading Halted Today
07:05am, Thursday, 27'th May 2021
RED BANK, N.J., May 27, 2021 /PRNewswire/ -- Provention Bio, Inc. (Nasdaq: PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that Na
PRVB Stock Price: 26.82% Increase Explanation
07:10am, Wednesday, 26'th May 2021
The stock price of Provention Bio, Inc., (Nasdaq: PRVB) increased by 26.82% yesterday. This is why it happened.
New York, New York--(Newsfile Corp. - May 25, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Pro
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Provention Bio, Inc. (PRVB) on Behalf of Investors
04:58pm, Tuesday, 25'th May 2021
BENSALEM, Pa.--(BUSINESS WIRE)---- $PRVB #CLASSACTION--Law Offices of Howard G. Smith announces an investigation on behalf of Provention Bio, Inc. ("Provention" or the "Company") (NASDAQ: PRVB) invest
Why Provention Bio Stock Is Trading Higher Today?
02:19pm, Tuesday, 25'th May 2021
The FDA published Provention Bio Inc's (NASDAQ: PRVB) teplizumab-related briefing documents ahead of an Advisory Committee meeting scheduled for May 27 (Thursday). The agency sounded a relatively
LOS ANGELES--(BUSINESS WIRE)---- $PRVB #PRVB--SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Provention Bio, Inc.
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Provention Bio, Inc. (NAS
PRVB Stock Price: Over 20% Increase Explanation
10:04am, Tuesday, 25'th May 2021
The stock price of Provention Bio Inc (NASDAQ: PRVB) increased by over 20% during intraday trading this morning. This is why it happened.
